Multicenter evaluation of a commercial cytomegalovirus quantitative standard: Effects of commutability on interlaboratory concordance

Journal of Clinical Microbiology

Volumn 51, Issue 11, 2013, Pages 3811-3817

  Hayden, R T ^a   Shahbazian, M D ^b   Valsamakis, A ^c   Boonyaratanakornkit, J ^b   Cook, L ^d,e   Pang, X L ^f,g   Preiksaitis, J K ^f   Schonbrunner E R ^b   Caliendo, A M ^h,i  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b Life Technologies   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^e Fred Hutchinson Cancer Research Center   (United States)

^f UNIVERSITY OF ALBERTA   (Canada)

^g PROVINCIAL LABORATORY FOR PUBLIC HEALTH   (Canada)

^h EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ EMORY CENTER FOR AIDS RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYSIS; ARTICLE; BIOASSAY; BLOOD SAMPLING; CALIBRATION; COMMERCIAL SPECIES; CONTROLLED STUDY; CYTOMEGALOVIRUS; HUMAN; HUMAN TISSUE; LABORATORY TEST; MAJOR CLINICAL STUDY; NONHUMAN; PAIRWISE ANALYSIS; PLOTS AND CURVES; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STANDARD;

CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; HUMANS; OBSERVER VARIATION; REFERENCE STANDARDS; VIRAL LOAD;

EID: 84886534001     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02036-13     Document Type: Article

References (20)

1. Hayden RT, Hokanson KM, Pounds SB, Bankowski MJ, Belzer SW, Carr J, Diorio D, Forman MS, Joshi Y, Hillyard D, Hodinka RL, Nikiforova MN, Romain CA, Stevenson J, Valsamakis A, Balfour HH, Jr, US EBV Working Group.2008.Multicenter comparison of different real-time PCR assays for quantitative detection of Epstein-Barr virus.J. Clin. Microbiol.46:157-163.
2. Hayden RT, Yan X, Wick MT, Rodriguez AB, Xiong X, Ginocchio CC, Mitchell MJ, Caliendo AM.2012.Factors contributing to variability of quantitative viral PCR results in proficiency testing samples: a multivariate analysis.J. Clin. Microbiol.50:337-345.
3. Pang XL, Fox JD, Fenton JM, Miller GG, Caliendo AM, Preiksaitis JK.2009.Interlaboratory comparison of cytomegalovirus viral load assays.Am.J.Transplant.9:258-268.
4. Preiksaitis JK, Pang XL, Fox JD, Fenton JM, Caliendo AM, Miller GG.2009.Interlaboratory comparison of Epstein-Barr virus viral load assays.Am.J.Transplant.9:269-279.
5. Wolff DJ, Heaney DL, Neuwald PD, Stellrecht KA, Press RD.2009.Multi-site PCR-basedCMVviral load assessment-assays demonstrate linearity and precision, but lack numeric standardization: a report of the association for molecular pathology.J.Mol.Diagn.11:87-92.
6. Holden MJ, Madej RM, Minor P, Kalman LV.2011.Molecular diagnostics: harmonization through reference materials, documentary standards and proficiency testing.Expert Rev.Mol.Diagn.11:741-755.
7. Madej RM, Davis J, Holden MJ, Kwang S, Labourier E, Schneider GJ.2010.International standards and reference materials for quantitative molecular infectious disease testing.J.Mol.Diagn.12:133-143.
8. Caliendo AM, Shahbazian MD, Schaper C, Ingersoll J, Abdul-Ali D, Boonyaratanakornkit J, Pang XL, Fox J, Preiksaitis J, Schonbrunner ER.2009.A commutable cytomegalovirus calibrator is required to improve the agreement of viral load values between laboratories.Clin. Chem.55: 1701-1710.
9. National Institute for Biological Standards and Control.2013.1st WHO international standard for Epstein-Barr virus for nucleic acid amplification techniques.NIBSC code 09/260, National Institute for Biological Standards and Control, Potters Bar, Hertfordshire, United Kingdom.
10. Fryer JF, Heath AB, Anderson R, Minor PD, Collaborative Study Group.2010.Collaborative study to evaluate the proposed 1st WHO international standard for human cytomegalovirus (HCMV) for nucleic acid amplification (NAT)-based assays.National Institute for Biological Standards and Control, Potters Bar, Hertfordshire, United Kingdom.
11. Haynes RJ, Kline MC, Toman B, Scott C, Wallace P, Butler JM, Holden MJ.2013.Standard reference material 2366 for measurement of human cytomegalovirus DNA.J.Mol.Diagn.15:177-185.
12. Fasce CF, Jr, Rej R, Copeland WH, Vanderlinde RE.1973.A discussion of enzyme reference materials: applications and specifications.Clin. Chem.19:5-9.
13. Miller WG, Myers GL, Rej R.2006.Why commutability matters.Clin. Chem.52:553-554.
14. Vesper HW, Miller WG, Myers GL.2007.Reference materials and commutability.Clin. Biochem. Rev.28:139-147.
15. Cattozzo G, Franzini C, d'Eril GV.2001.Myoglobin and creatine kinase isoenzyme MB mass assays: intermethod behaviour of patient sera and commercially available control materials.Clin.Chim.Acta 303:55-60.
16. Cattozzo G, Franzini C, Melzi d'Eril GM.2001.Commutability of calibration and control materials for serum lipase.Clin. Chem.47:2108-2113.
17. Eckfeldt JH, Copeland KR.1993.Accuracy verification and identification of matrix effects.The College of American Pathologists' protocol.Arch.Pathol.Lab. Med.117:381-386.
18. Franzini C, Ceriotti F.1998.Impact of reference materials on accuracy in clinical chemistry.Clin.Biochem.31:449-457.
19. ISO.2009.In vitro diagnostic medical devices-measurement of quantities in samples of biological origin-requirements for certified reference materials and the content of supporting documentation.ISO 15194:2009.ISO, Geneva, Switzerland.
20. Ross JW, Miller WG, Myers GL, Praestgaard J.1998.The accuracy of laboratory measurements in clinical chemistry: a study of 11 routine chemistry analytes in the College of American Pathologists Chemistry Survey with fresh frozen serum, definitive methods, and reference methods.Arch.Pathol.Lab.Med.122: 587-608.